For researchers who have switched from one to the other, the guides on switching from tirzepatide to semaglutide and the semaglutide to tirzepatide conversion chart are useful references for the transition period
The main concerns with GLP-1 agonist drugs include: GI side effects (nausea, diarrhea, vomiting, constipation, abdominal pain) High out-of-pocket cost for those who do not quality under insurance Risk of inadequate nutrition (reduced intake + insufficient nutrition counseling) Significant loss of muscle mass & bone density High discontinuation rates (with lost weight regained) Limited public & clinician knowledge on importance/implementation of nutrition and lifestyle changes Side Effects and Costs of GLP-1 Medications The use of GLP-1 drugs has been associated with numerous side effects, ranging from mild to severe
or with a BMI of 27 or more and pre-diabetes, previous myocardial infarction, previous stroke, or symptomatic peripheral artery disease
Here are some of the most cited benefits with quantitative evidence: Increased Procollagen Synthesis: Studies showed topical GHK-Cu increased procollagen production in 70% of subjects, outperforming Vitamin C (50%) and tretinoin (40%)
It's available on Amazon or from Lifelink Last edited: #5 I also noticed in Roops signature that you are giving 5 units of insulin